Low-Temperature Graphene Growth by Forced Convection of Plasma-Excited Radicals.

We developed the forced convection (FC)-PECVD method for the synthesis of graphene, in which a specially designed blowing plasma source is used at moderate gas pressure (1-10 Torr) and the distribution of reactive radicals reaching the substrate surface can be controlled by forced convection. Self-limiting growth of graphene occurs on copper foil, and monolayer graphene growth with a few defects is achieved even at low temperatures (<400 °C). We also demonstrated the enlargement of the growth area using the scalable blowing plasma source. We expect that the FC-PECVD method overcomes the limitations of conventional low-temperature PECVD and provides a breakthrough for the achievement of industrial applications based on graphene.

Plasma-activated medium (PAM) kills human cancer-initiating cells.

Medical non-thermal plasma (NTP) treatments for various types of cancers have been reported. Cells with tumorigenic potential (cancer-initiating cells; CICs) are few in number in many types of tumors. CICs efficiently eliminate anti-cancer chemicals and exhibit high-level aldehyde dehydrogenase (ALDH) activity. We previously examined the effects of direct irradiation via NTP on cancer cells; even though we targeted CICs expressing high levels of ALDH, such treatment affected both non-CICs and CICs. Recent studies have shown that plasma-activated medium (PAM) (culture medium irradiated by NTP) selectively induces apoptotic death of cancer but not normal cells. Therefore, we explored the anti-cancer effects of PAM on CICs among endometrioid carcinoma and gastric cancer cells. PAM reduced the viability of cells expressing both low and high levels of ALDH. Combined PAM/cisplatin appeared to kill cancer cells more efficiently than did PAM or cisplatin alone. In a mouse tumor xenograft model, PAM exerted an anti-cancer effect on CICs. Thus, our results suggest that PAM effectively kills both non-CICs and CICs, as does NTP. Therefore, PAM may be a useful new anti-cancer therapy, targeting various cancer cells including CICs.

Low temperature plasma equipment applied on surgical hemostasis and wound healings.

Low temperature plasma (LTP) coagulation equipment, which avoids causing burn injuries to patients, has been introducing into minimally invasive surgery. The mechanism by which this equipment stops bleeding is to directly occupy the injury with the formed blood clots, and different from the mechanism of the common electrical hemostatic devices that cauterize the tissues around the bleeding to stem the blood flow. A noteworthy point is that LTP treatment with our equipment is not confined only to the blood coagulation system, but it has significant effects on the other blood components to form clots with or without hemolysis, and that there is a plasma current threshold that determines whether the treatment makes stable clots. In this review, we introduce the clinical benefits of LTP current and describe the clot formation it facilitates.

Galectin expression in healing wounded skin treated with low-temperature plasma: Comparison with treatment by electronical coagulation.

Low-temperature plasma is useful for the care of wounded skin. It accelerates wound healing. However, the mechanism of this effect has not been fully elucidated yet. Galectin-1 is reported to accelerate wound healing via the Smad signaling pathway. In the present study to clarify whether or not galectins were expressed during the process of wound healing in the plasma-treated skin, we examined the effect of low-temperature plasma on galectin expression in the healing skin. We compared the effects of low-temperature plasma on the expression of galectin-1, -2, and -3 in the healing skin with those of electrocoagulation conducted with a high-frequency electrical coagulator. Immediately after the start of low-temperature plasma treatment following the incision made in the skin, a membrane-like structure was formed on the surface of the wound. Immunoelectron microscopy showed that these galectins were localized in the membrane-like structure of the plasma-treated skin. The expressions of these galectins were increased by the low-temperature plasma treatment, whereas they were inhibited by the electrocoagulation. These results suggest that galectins were involved in the wound healing of low-temperature plasma-treated skin. Galectins will thus be good markers for further examination of the effects of low-temperature plasma on the healing of wounded skin.

Red blood cell coagulation induced by low-temperature plasma treatment.

Low-temperature plasma (LTP) treatment promotes blood clot formation by stimulation of the both platelet aggregation and coagulation factors. However, the appearance of a membrane-like structure in clots after the treatment is controversial. Based on our previous report that demonstrated characteristics of the form of coagulation of serum proteins induced by LTP treatment, we sought to determine whether treatment with two plasma instruments, namely BPC-HP1 and PN-110/120TPG, formed clots only from red blood cells (RBCs). LTP treatment with each device formed clots from whole blood, whereas LTP treatment with BPC-HP1 formed clots in phosphate-buffered saline (PBS) containing 2 × 10(9)/mL RBCs. Light microscopic analysis results showed that hemolysis formed clots consisting of materials with membrane-like structures from both whole blood and PBS-suspended RBCs. Moreover, electron microscopic analysis results showed a monotonous material with high electron density in the formed clots, presenting a membrane-like structure. Hemolysis disappeared with the decrease in the current through the targets contacting with the plasma flare and clot formation ceased. Taken together, our results and those of earlier studies present two types of blood clot formation, namely presence or absence of hemolysis capability depending on the current through the targets.

Quantitative Evidence for the Dependence of Highly Crystalline Single Wall Carbon Nanotube Synthesis on the Growth Method.

We present a study quantitatively demonstrating that the method of synthesis (gas phase, fixed bed, non-fixed bed) represents a determining factor in the level of crystallinity in growing single wall carbon nanotubes (SWCNTs). Using far infrared spectroscopy, the "effective length" (associated with the level of crystallinity) was estimated for CNTs grown using various synthetic methods (lab-produced and supplemented by commercially purchased SWCNTs) as a metric for crystallinity (i.e., defect density). Analysis of the observed "effective lengths" showed that the SWCNTs fell into two general groups: long and short (high and low crystallinity) synthesized by gas-phase methods and all other supported catalyst methods, respectively. Importantly, the "long" group exhibited effective lengths in the range of 700-2200 nm, which was greater than double that of the typical values representing the "short" group (110-490 nm). These results highlight the significant difference in crystallinity. We interpret that the difference in the crystallinity stemmed from stress concentration at the nanotube-catalyst interface during the growth process, which originated from various sources of mismatch in growth rates (e.g., vertically aligned array) as well as impact stress from contact with other substrates during fluidization or rotation. These results are consistent with well-accepted belief, but now are demonstrated quantitatively.

Role of Hydrogen in Catalyst Activation for Plasma-Based Synthesis of Carbon Nanotubes.

The importance of hydrogen in carbon nanotube (CNT) synthesis has been known as it supports the critical processes necessary for CNT growth, such as catalyst reduction. However, within the scope of our mini microplasma CNT synthesis reactor, we found that hydrogen was critical for unexpected reasons. Without hydrogen, CNT growth was inhibited and characterized by amorphous carbon particles. Optical emission spectroscopy of the microplasma revealed that without hydrogen, the high-energy electrons induced the immediate decomposition of carbon feedstock simultaneously with the catalyst feedstock, thus suppressing the formation of catalyst nanoparticles and inducing catalyst deactivation. In contrast, the inclusion of hydrogen induced less-immediate decomposition of reactant gases, through the conversion of electron energy of the plasma to thermal energy, which provided the appropriate conditions for catalyst nanoparticle formation and subsequent CNT nucleation. A simple reaction pathway model was proposed to explain these observed results and underlying mechanisms.

Oxygen-doped carbon nanotubes for near-infrared fluorescent labels and imaging probes.

Chemical modification of carbon nanotube surface can controllably modulate their optical properties. Here we report a simple and effective synthesis method of oxygen-doped single-walled carbon nanotubes (o-SWCNTs), in which a thin film of SWCNTs is just irradiated under the UV light for a few minutes in air. By using this method, the epoxide-type oxygen-adducts (ep-SWCNTs) were produced in addition to the ether-type oxygen-adducts (eth-SWCNTs). The Treated (6, 5) ep-SWCNTs show a red-shifted luminescence at ~1280 nm, which corresponds to the most transparent regions for bio-materials. Immunoassay, fluorescence vascular angiography and observation of the intestinal contractile activity of mice were demonstrated by using the produced o-SWCNTs as infrared fluorescent labels and imaging agents.

Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma.

Nonequilibrium atmospheric pressure plasma (NEAPP) is a novel approach for blood coagulation, wound healing, and tumor elimination. NEAPP not only directly but also indirectly affects living cells via the medium exposed to NEAPP-yielding devises, called plasma-activated medium (PAM). The conservable and portable PAM serves as an alternative and advantageous approach over direct NEAPP. Here we examined the effect of PAM on lymphoplasmacytic lymphoma (LPL) cell lines. We found that PAM induced plasma cell differentiation and reduced tumorigenic population. PAM increased the expression level of PRDM1α, which is a transcription factor promoting plasma cell differentiation, suggesting that plasma cell differentiation of LPL might be mediated by PRDM1α. We previously reported that plasma cell component of LPL is vulnerable to apoptosis and less tumorigenic. These findings suggested that PAM treatment might become a novel therapy against LPL by inducing the transition from tumorigenic to non-tumorigenic population.